NYSE:AVNS - Avanos Medical Stock Price, Forecast & News

Avanos Medical's stock was trading at $29.01 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, AVNS stock has decreased by 6.9% and is now trading at $27.02. View which stocks have been mosted impacted by Coronavirus.

6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Avanos Medical in the last year. There are currently 2 sell ratings, 3 hold ratings and 1 buy rating for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for Avanos Medical.

Avanos Medical is scheduled to release its next quarterly earnings announcement on Tuesday, May 5th 2020. View our earnings forecast for Avanos Medical.

Avanos Medical Inc (NYSE:AVNS) announced its quarterly earnings results on Tuesday, February, 25th. The company reported $0.34 EPS for the quarter, beating analysts' consensus estimates of $0.32 by $0.02. The firm earned $189.80 million during the quarter, compared to the consensus estimate of $178.58 million. Avanos Medical had a positive return on equity of 3.99% and a negative net margin of 6.58%. The firm's quarterly revenue was up 11.7% on a year-over-year basis. During the same period last year, the firm posted $0.30 earnings per share. View Avanos Medical's earnings history.

Avanos Medical issued an update on its FY20 earnings guidance on Tuesday, February, 25th. The company provided earnings per share guidance of $1.00-1.20 for the period, compared to the Thomson Reuters consensus estimate of $1.16. The company issued revenue guidance of +5-7% yr/yr to $732.5-746.4 million, compared to the consensus revenue estimate of $736.83 million.

6 brokerages have issued 12 month price objectives for Avanos Medical's stock. Their forecasts range from $29.00 to $48.00. On average, they anticipate Avanos Medical's stock price to reach $34.80 in the next year. This suggests a possible upside of 28.8% from the stock's current price. View analysts' price targets for Avanos Medical.

News headlines about AVNS stock have trended negative recently, according to InfoTrie Sentiment Analysis. The research firm scores the sentiment of news coverage by monitoring more than six thousand news and blog sources in real time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Avanos Medical earned a coverage optimism score of -2.4 on InfoTrie's scale. They also assigned news headlines about the company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an effect on the stock's share price in the next several days. View the latest news aboutAvanos Medical.

Avanos Medical saw a increase in short interest in February. As of February 28th, there was short interest totaling 3,230,000 shares, an increase of 11.0% from the February 13th total of 2,910,000 shares. Based on an average daily volume of 374,300 shares, the days-to-cover ratio is presently 8.6 days. Currently, 6.8% of the company's stock are short sold. View Avanos Medical's Current Options Chain.

Some companies that are related to Avanos Medical include Wright Medical Group (WMGI), MSA Safety (MSA), Wound Management Technologies (WNDM), Inogen (INGN), Establishment Labs (ESTA), Invacare (IVC), RTI Surgical (RTIX), Lakeland Industries (LAKE), Sientra (SIEN), Allied Healthcare Products (AHPI), ConforMIS (CFMS), COLLPLANT HOLDI/S (CLGN), Histogenics (HSGX), NanoVibronix (NAOV) and Bionik Laboratories (BNKL).

Based on aggregate information from My MarketBeat watchlists, some companies that other Avanos Medical investors own include Kimberly Clark (KMB), AT&T (T), Honeywell International (HON), Alibaba Group (BABA), CVS Health (CVS), Home Depot (HD), Altria Group (MO), Procter & Gamble (PG), Verizon Communications (VZ) and Cisco Systems (CSCO).

Avanos Medical trades on the New York Stock Exchange (NYSE) under the ticker symbol "AVNS."

Avanos Medical's stock is owned by a number of retail and institutional investors. Top institutional shareholders include Champlain Investment Partners LLC (6.96%), Paradice Investment Management LLC (4.64%), State Street Corp (3.78%), Victory Capital Management Inc. (3.45%), Victory Capital Management Inc. (3.42%) and Goldman Sachs Group Inc. (3.11%). Company insiders that own Avanos Medical stock include John W Wesley, Joseph Fralin Woody and Steven E Voskuil. View institutional ownership trends for Avanos Medical.

AVNS stock was sold by a variety of institutional investors in the last quarter, including Victory Capital Management Inc., Victory Capital Management Inc., FMR LLC, Heartland Advisors Inc., Paradice Investment Management LLC, Jacobs Levy Equity Management Inc., California Public Employees Retirement System, and Bank of New York Mellon Corp. View insider buying and selling activity for Avanos Medical.

AVNS stock was purchased by a variety of institutional investors in the last quarter, including Janus Henderson Group PLC, Champlain Investment Partners LLC, Norges Bank, Schonfeld Strategic Advisors LLC, Cove Street Capital LLC, Confluence Investment Management LLC, Eagle Asset Management Inc., and Macquarie Group Ltd.. Company insiders that have bought Avanos Medical stock in the last two years include John W Wesley, Joseph Fralin Woody, and Steven E Voskuil. View insider buying and selling activity for Avanos Medical.

Shares of AVNS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of AVNS stock can currently be purchased for approximately $27.02.

Avanos Medical has a market capitalization of $1.29 billion and generates $697.60 million in revenue each year. The company earns $-45,900,000.00 in net income (profit) each year or $1.07 on an earnings per share basis. Avanos Medical employs 4,700 workers across the globe. View additional information about Avanos Medical.

The official website for Avanos Medical is http://avanos.com/.

Avanos Medical's mailing address is 5405 WINDWARD PARKWAY, ALPHARETTA GA, 30004. The company can be reached via phone at 844-428-2667 or via email at [email protected]